These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

802 related articles for article (PubMed ID: 29715359)

  • 21. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF; Lai CL
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues.
    Jansen L; Kootstra NA; van Dort KA; Takkenberg RB; Reesink HW; Zaaijer HL
    J Infect Dis; 2016 Jan; 213(2):224-32. PubMed ID: 26216905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients.
    Jung SK; Kim KA; Ha SY; Lee HK; Kim YD; Lee BH; Paik WH; Kim JW; Bae WK; Kim NH; Lee JS; Jwa YJ
    Clin Mol Hepatol; 2015 Mar; 21(1):41-8. PubMed ID: 25834801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
    de Niet A; Jansen L; Stelma F; Willemse SB; Kuiken SD; Weijer S; van Nieuwkerk CMJ; Zaaijer HL; Molenkamp R; Takkenberg RB; Koot M; Verheij J; Beuers U; Reesink HW
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):576-584. PubMed ID: 28522204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peg-interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti-HBV efficacy and long-term survival among HBV DNA-positive hepatocellular carcinoma patients after hepatectomy/ablation.
    Qi W; Zhang Q; Xu Y; Wang X; Yu F; Zhang Y; Zhao P; Guo H; Zhou C; Wang Z; Sun Y; Liu L; Xuan W; Wang J
    J Viral Hepat; 2020 Apr; 27(4):387-396. PubMed ID: 31755220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Interdisciplinary aspects of and new drugs for chronic hepatitis B].
    Horváth G
    Orv Hetil; 2013 Jul; 154(29):1142-50. PubMed ID: 23853347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of tenofovir and entecavir in patients who relapsed after pegylated interferon therapy.
    Köse Ş; Tatli Kiş T; Atalay S
    J Chemother; 2019 Jul; 31(4):209-213. PubMed ID: 30963812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
    Lindh M; Uhnoo I; Bläckberg J; Duberg AS; Friman S; Fischler B; Karlström O; Norkrans G; Reichard O; Sangfeldt P; Söderström A; Sönnerborg A; Weiland O; Wejstål R; Wiström J
    Scand J Infect Dis; 2008; 40(6-7):436-50. PubMed ID: 18584530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and management of drug resistant hepatitis B virus infections.
    Wang C; Fan R; Sun J; Hou J
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1432-40. PubMed ID: 22694205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B.
    Lo AO; Wong VW; Wong GL; Tse YK; Chan HY; Chan HL
    Aliment Pharmacol Ther; 2015 Jun; 41(11):1190-9. PubMed ID: 25825194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Taiwan consensus statement on the management of chronic hepatitis B.
    Chien RN; Kao JH; Peng CY; Chen CH; Liu CJ; Huang YH; Hu TH; Yang HI; Lu SN; Ni YH; Chuang WL; Lee CM; Wu JC; Chen PJ; Liaw YF
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):7-38. PubMed ID: 30527436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study].
    Hu P; Shang J; Zhang WH; Gong GZ; Li YG; Chen XY; Jiang JN; Xie Q; Dou XG; Sun YT; Li YF; Liu YX; Liu GZ; Ma DW; Chi XL; Tang H; Li XO; Xie Y; Chen XP; Jiang JJ; Zha P; Hou JL; Gao ZL; Fan HM; Ding JG; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2018 Oct; 26(10):756-764. PubMed ID: 30481882
    [No Abstract]   [Full Text] [Related]  

  • 36. Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.
    Jones J; Colquitt J; Shepherd J; Harris P; Cooper K
    Health Technol Assess; 2010 May; 14 Suppl 1():23-9. PubMed ID: 20507800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B.
    Wi CI; Kim WR; Gross JB; Stadheim LM; Poterucha JJ
    Gut Liver; 2016 Jul; 10(4):611-6. PubMed ID: 26190580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a Functional Cure for Hepatitis B.
    Lok ASF
    Gut Liver; 2024 Jul; 18(4):593-601. PubMed ID: 38533651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antiviral treatment of chronic B hepatitis; 2010 - therapeutic recommendations].
    Juszczyk J; Boroń-Kaczmarska A; Cianciara J; Flisiak R; Gładysz A; Halota W; Kryczka W; Malkowski P; Pawlowska M; Simon K;
    Pol Merkur Lekarski; 2010 Aug; 29(170):103-6. PubMed ID: 20842822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors.
    Qiu LP; Chen L; Chen KP
    Fundam Clin Pharmacol; 2014 Aug; 28(4):364-81. PubMed ID: 24118072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.